Cargando…
Editorial: Real-world experience with CFTR modulator therapy
Autores principales: | Tümmler, Burkhard, Burgel, Pierre-Régis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682817/ https://www.ncbi.nlm.nih.gov/pubmed/38035017 http://dx.doi.org/10.3389/fphar.2023.1331829 |
Ejemplares similares
-
Post-approval studies with the CFTR modulators Elexacaftor-Tezacaftor—Ivacaftor
por: Tümmler, Burkhard
Publicado: (2023) -
CFTR Modulators in People with Cystic Fibrosis: Real-World Evidence in France
por: Regard, Lucile, et al.
Publicado: (2022) -
Real-world disparities and ethical considerations with access to CFTR modulator drugs: Mind the gap!
por: Zampoli, M., et al.
Publicado: (2023) -
Differential effects of ELX/TEZ/IVA on organ-specific CFTR function in two patients with the rare CFTR splice mutations c.273+1G>A and c.165-2A>G
por: Pallenberg, Sophia T., et al.
Publicado: (2023) -
Real-life impact of highly effective CFTR modulator therapy in children with cystic fibrosis
por: Olivier, Margarete, et al.
Publicado: (2023)